The objective of this study is to evaluate third-trimester fetal liver biometry, to predict birth weight and cord markers at birth in diabetic pregnancies. There are no previous works comparing ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--What’s New: Samsung Medison and Intel are collaborating on new smart workflow solutions to improve obstetric measurements that contribute to maternal and fetal ...
Clarius Mobile Health Corp. received U.S. FDA clearance for the Clarius OB artificial intelligence biometric measurement tool, which is designed to improve access to accurate prenatal monitoring in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results